EC
EcoR1 Capital’s Oric Pharmaceuticals ORIC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.4M | Sell |
1,618,068
-1,800,000
| -53% | -$18.3M | 0.97% | 21 |
|
|
2025
Q1 | $19.1M | Hold |
3,418,068
| – | – | 1.13% | 15 |
|
|
2024
Q4 | $27.6M | Hold |
3,418,068
| – | – | 1.04% | 20 |
|
|
2024
Q3 | $35M | Hold |
3,418,068
| – | – | 1.2% | 21 |
|
|
2024
Q2 | $24.2M | Hold |
3,418,068
| – | – | 0.74% | 27 |
|
|
2024
Q1 | $47M | Hold |
3,418,068
| – | – | 1.19% | 21 |
|
|
2023
Q4 | $31.4M | Hold |
3,418,068
| – | – | 0.82% | 24 |
|
|
2023
Q3 | $20.7M | Hold |
3,418,068
| – | – | 0.7% | 27 |
|
|
2023
Q2 | $26.5M | Hold |
3,418,068
| – | – | 0.65% | 20 |
|
|
2023
Q1 | $19.5M | Hold |
3,418,068
| – | – | 0.63% | 29 |
|
|
2022
Q4 | $20.1M | Hold |
3,418,068
| – | – | 0.61% | 27 |
|
|
2022
Q3 | $10.9M | Hold |
3,418,068
| – | – | 0.32% | 37 |
|
|
2022
Q2 | $15.3M | Hold |
3,418,068
| – | – | 0.53% | 32 |
|
|
2022
Q1 | $18.3M | Sell |
3,418,068
-50,876
| -1% | -$272K | 0.57% | 34 |
|
|
2021
Q4 | $51M | Hold |
3,468,944
| – | – | 1.63% | 18 |
|
|
2021
Q3 | $72.5M | Buy |
3,468,944
+376,726
| +12% | +$7.88M | 2.52% | 11 |
|
|
2021
Q2 | $54.7M | Hold |
3,092,218
| – | – | 2.04% | 13 |
|
|
2021
Q1 | $75.8M | Hold |
3,092,218
| – | – | 3.36% | 10 |
|
|
2020
Q4 | $105M | Buy |
3,092,218
+450,000
| +17% | +$15.2M | 5.63% | 6 |
|
|
2020
Q3 | $66.1M | Hold |
2,642,218
| – | – | 4.71% | 7 |
|
|
2020
Q2 | $89.1M | Buy |
+2,642,218
| New | +$89.1M | 6.58% | 3 |
|